The objective is to assess the functional and clinical effects of ACS in TFCC injuries.
Materials and Procedures A) Research conducted between September 2019 and December 2021 on 28 cases.
B) For this study, 28 patients with radiological and clinical evidence of TFCC injuries resulting from sporting activities were enrolled.
C) A clinical diagnosis is made using plain radiographs, ultrasonography, and an MRI. 26 cases were presented for full follow-up. After injection, follow-up was lost in 2 cases. At the end of six weeks, there were 16 cases with excellent results, 6 cases with good results, and 4 cases with poor results. But after three months, follow-up with 22 cases (16+06) yielded a wholly favourable response, thus we classified them as having excellent results. 04 Cases Were Given Another Shot Of ACS And Gave Good Response At The End Of 6 Weeks After 2nd ACS Injection. They Had Poor Results At The End Of 6 Weeks.
As a result of ACS Therapy, we have discovered that pain can be significantly decreased and healing can be accelerated. Fast-acting medication offers long-lasting relief. Time to Return to Sporting and Gym Activities Also Decreased Compared to Conventional Treatment, Which Is 3 Months, Whereas in this Study We Found Time to Return to Gym & Sports-Related Activities Took 6 Weeks. We believe that ACS is a safe way to treat Type 1 TFCC injuries since it allows for a quicker return to activity and pain relief without the risk of complications.
Author (s) Details
Satya Kumar Koduru
Department of Orthopaedics, NRI Academy of
Sciences, Chinakakani, Guntur (Dt), Andhra Pradesh, India.
View Book :- https://stm.bookpi.org/CPMS-V6/article/view/7680
No comments:
Post a Comment